The pyruvate kinase M2 isoform (PKM2) phosphorylates Bcl2 and directly inhibits apoptosis, demonstrating that the HSP90-PKM2-Bcl2 axis is a potential target for therapeutic intervention in GBM (22). The gene discussed is BCL2; the disease is glioblastoma.